MULTIDISCIPLINARY TEACHING COURSE ON LUNG CANCER
Nice, French Riviera, October 28-30, 2010

Course director

Paul Van Houtte, Radiation Oncologist, Institut Bordet, Brussels (BE)

Teachers

Pierre Yves Bondiau, Radiation Oncologist, Cenre A LAcassagne, Nice (FR)
Dirk De Ruysscher, Radiation Oncologist, MAASTRO Clinic/University Hospital, Maastricht (NL)
Enriqueta Felip, Medical Oncologist, Valle d’Hebron University Hospital, Barcelona (ES)
Jaroslaw Kuždžal, Thoracic Surgeon, John Paul II Hospital, Krakow (PL)
René Mirimanoff, Radiation Oncologist, CHUV, Lausanne (CH)
Rolf Stahel, Medical Oncologist, Poliklinik Onkologie, UniversitätsSpital, Zürich (CH)
Gonzalo Varela, Thoracic Surgeon, Hospital Universitario de Salamanca (ES)

Course aims

This advanced multidisciplinary course, jointly organized by ESTRO, ESMO, EACTS, ESTS, ESSO aims to promote an integrated approach to the diagnosis and management of lung cancer. The goal is to individualize the patient treatment approach based on the clinical presentation, prognostic factors, tumour extent and the patient. In the last decades, we have seen major technical and clinical improvements both for the diagnosis (including the different imaging procedures) and the treatment (surgery, radiotherapy, chemotherapy and targeted therapies) for this very common and aggressive tumour, with clear benefit for the patients.

The course will be very interactive through the integration of lectures, debates and cases discussions and definitely multidisciplinary with a programme outlining the different treatments for lung cancer from evidence based medicine to the on-going research. The faculty will include chest physicians, radiologists, medical oncologists, thoracic surgeons and radiation oncologists.

 Target Group

The course is meant specialists and trainees with some expertise in radiotherapy, surgery or chemotherapy that are interested in the management of lung cancer.

 Educational Programme

§         Pitfalls in imaging procedures
§         PET in daily clinical practice
§         The biology of lung cancer  
§         Patient evaluation before radical treatment
§         From mediastinal staging to lobectomy with lymph node dissection  
§         Adjuvant & neo-adjuvant chemotherapy for resectable tumours  
§         Chemotherapy or chemo-radiotherapy for borderline resectable tumours 
§         The limitations of surgery for stage III tumours
§         Is there still a place for postoperative radiotherapy
§         State-of-the-art chest radiotherapy 
§         Chemoradiotheapy for locally advanced NSCLC
§         The oligometastatic concept  
§         The use of molecular markers
§         Assessment of tumour response
§         Management of acute and late effects of chemoradiotherapy
§         The challenge of brain metastases 
§         Integration and organization of supportive care
§         Multimodality treatment of SCLC
§         Clinical case discussions